Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-04-02 5:00 pm Purchase | 2025-03-31 | 13D | Avenue Therapeutics, Inc. ATXI | Fortress Biotech Inc. FBIO | 328,746 10.300% | 33,724 (+11.43%) | Filing History |
| 2025-02-14 5:01 pm Sale | 2024-12-31 | 13G | Avenue Therapeutics, Inc. ATXI | Armistice Capital, LLC | 100,400 4.990% | -14,600 (-12.70%) | Filing History |
| 2025-02-14 1:25 pm Purchase | 2024-12-31 | 13G | Avenue Therapeutics, Inc. ATXI | Ikarian Capital, LLC | 140,000 6.800% | 140,000 (New Position) | Filing History |
| 2025-01-03 5:50 pm Purchase | 2024-12-31 | 13D | Avenue Therapeutics, Inc. ATXI | Fortress Biotech Inc. FBIO | 295,022 13.800% | 114,597 (+63.52%) | Filing History |
| 2024-11-15 4:05 pm Purchase | 2024-11-13 | 13D | Avenue Therapeutics, Inc. ATXI | Fortress Biotech Inc. FBIO | 180,425 8.900% | 180,425 (New Position) | Filing History |
| 2024-11-14 3:22 pm Purchase | 2024-09-30 | 13G | Avenue Therapeutics, Inc. ATXI | Armistice Capital, LLC | 115,000 7.210% | 115,000 (New Position) | Filing History |
| 2024-05-02 4:02 pm Purchase | 2024-05-02 | 13G | Avenue Therapeutics, Inc. ATXI | Davidow Robert L | 17,206 2.900% | 17,206 (New Position) | Filing History |
| 2024-04-17 4:05 pm Purchase | 2024-04-16 | 13D | Avenue Therapeutics, Inc. ATXI | Fortress Biotech Inc. FBIO | 47,521 8.000% | 33,533 (+239.74%) | Filing History |
| 2024-01-02 3:45 pm Purchase | 2023-12-31 | 13G | Avenue Therapeutics, Inc. ATXI | SABBY MANAGEMENT LLC | 8,814 11.000% | 5,294 (+150.40%) | Filing History |
| 2023-12-13 4:03 pm Sale | 2023-12-11 | 13G | Avenue Therapeutics, Inc. ATXI | Davidow Robert L | 17,464 9.890% | -8,227 (-32.02%) | Filing History |
| 2023-11-28 4:05 pm Purchase | 2023-10-31 | 13G | Avenue Therapeutics, Inc. ATXI | Davidow Robert L | 25,691 14.500% | 25,691 (New Position) | Filing History |
| 2023-09-18 5:08 pm Purchase | 2023-09-08 | 13D | Avenue Therapeutics, Inc. ATXI | Fortress Biotech Inc. FBIO | 13,987 12.100% | 13,987 (New Position) | Filing History |
| 2023-02-14 11:22 am Sale | 2022-12-31 | 13G | Avenue Therapeutics, Inc. ATXI | CVI Investments, Inc. | 3,347 4.900% | -289 (-7.95%) | Filing History |
| 2023-01-06 4:31 pm Purchase | 2022-12-31 | 13D | Avenue Therapeutics, Inc. ATXI | Fortress Biotech Inc. FBIO | 7,710 11.300% | 4,296 (+125.86%) | Filing History |
| 2023-01-04 08:25 am Purchase | 2022-12-31 | 13G | Avenue Therapeutics, Inc. ATXI | SABBY MANAGEMENT LLC | 3,520 11.000% | 3,520 (New Position) | Filing History |
| 2022-12-14 4:06 pm Sale | 2022-12-14 | 13G | Avenue Therapeutics, Inc. ATXI | Nantahala Capital Management, LLC | 0 0.000% | -1,292 (Position Closed) | Filing History |
| 2022-10-19 07:26 am Sale | 2022-10-11 | 13D | Avenue Therapeutics, Inc. ATXI | InvaGen Pharmaceuticals Inc. | 0 0.000% | -9,476 (Position Closed) | Filing History |
| 2022-10-17 12:01 pm Purchase | 2022-10-07 | 13G | Avenue Therapeutics, Inc. ATXI | CVI Investments, Inc. | 3,636 6.600% | 3,636 (New Position) | Filing History |
| 2022-10-17 06:01 am Purchase | 2022-10-11 | 13G | Avenue Therapeutics, Inc. ATXI | Mitchell P. Kopin | 2,891 4.990% | 2,891 (New Position) | Filing History |
| 2022-07-28 4:30 pm Purchase | 2022-07-25 | 13D | Avenue Therapeutics, Inc. ATXI | InvaGen Pharmaceuticals Inc. | 9,476 46.950% | 533 (+5.96%) | Filing History |